Meixiang Huang

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice

M. Bedoni, R. Kannan, S. Picciolini, 2023, Pharmaceutics.

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

D. Kapogiannis, Benjamin J Bell, A. Pal, 2023, Translational Neurodegeneration.

GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice

B. Slusher, Meixiang Huang, Kaitlyn D. J. Huizar, 2024, International journal of molecular sciences.